Early research (Phase 1)Study completedNCT02144051
What this trial is testing
Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors
Who this might be right for
Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor
AstraZeneca 32